The approach could enable 30-minute testing for a heart condition that is newly treatable following recent drug approvals.

Owner Zishan Alvi submitted claims for COVID-19 tests that were either never performed or were performed incorrectly, releasing potentially false negative test results to patients.

NEW YORK – Qiagen announced on Wednesday that it has launched a third-party partnering program for its clinical digital PCR platform and signed an agreement with the program's inaugural partner, South ...

NEW YORK – In a letter to customers on Wednesday, Bio-Rad Laboratories announced that it has decided against implementing a tariff surcharge that it said in May 21 it was considering for at least some ...

NEW YORK – Grail on Wednesday reported positive top-line performance and safety results from its Pathfinder 2 study, finding that adding its multi-cancer early detection (MCED) test to ...

NEW YORK – Caris Life Sciences went public this week with the goals of further expanding its customer base and getting closer to profitability, executives said in an interview after the company's ...

NEW YORK — EDX Medical Group said Monday that it has a signed a memorandum of understanding with UK-based healthcare group Spire Healthcare around diagnostic products and testing services.

The shares are expected to begin trading on June 18 under the ticker symbol CAI, and the offering is expected to close on June 20.

Last week, readers were most interested in a story about reports of a possible sale by Thermo Fisher Scientific of parts of its diagnostics business.